Zobrazeno 1 - 10
of 18
pro vyhledávání: '"S J, Weir"'
Autor:
R Smith, Eann S. Munro, S J Weir, R E McIntosh, J M Sandilands, A S Mayes, Patricia A. Noguera, Iveta Matejusova
Publikováno v:
Journal of fish diseases. 38(4)
Viral haemorrhagic septicaemia (VHS) is an infectious disease of farmed and wild fish and has an extensive host range in both freshwater and marine environments. In December 2012, a wrasse population consisting of ballan, Labrus bergylta (Ascanius),
Publikováno v:
Journal of clinical pharmacy and therapeutics. 36(2)
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone (ciclopirox) and specifically its olamine salt 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone 2-aminoethanol salt (ciclopirox olamine) are anti-fungal agents currently used for the treatment of mild to m
Publikováno v:
Circulation. 86:1421-1428
BACKGROUND Diltiazem, a calcium channel blocker, has been shown to be safe and effective in the treatment of patients in atrial fibrillation and/or atrial flutter. However, there have been no pharmacokinetic/pharmacodynamic studies of diltiazem in th
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(5)
To characterize the pharmacokinetics of rifapentine following single, multiple, and intermittent doses.Twenty-three healthy male volunteers were randomized in a two-period, incomplete block, crossover design to receive two of four possible treatments
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(5)
To determine the effects of rifapentine on hepatic mixed function oxidase activity and to assess the effect of enzyme induction on the steady-state pharmacokinetics of rifapentine.Twenty-three healthy males were randomized to receive two of the follo
Publikováno v:
Biopharmaceuticsdrug disposition. 20(1)
The single- and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover desig
Publikováno v:
Biopharmaceuticsdrug disposition. 20(1)
In this first part of a two-part investigation, the intravenous dose proportionality of dolasetron mesylate, a 5-HT3 receptor antagonist, and the absolute bioavailability of oral dolasetron mesylate were investigated. In an open-label, randomized, fo
Publikováno v:
Biopharmaceuticsdrug disposition. 19(7)
The pharmacokinetics and dose proportionality of fexofenadine, a new non-sedating antihistamine, and its enantiomers were characterized after single and multiple-dose administration of its hydrochloride salt. A total of 24 healthy male volunteers (31
Publikováno v:
Journal of pharmacokinetics and biopharmaceutics. 26(1)
Gender can be an important variable in the absorption and disposition of some drugs. In this open-label study, 15 healthy, nonsmoking women received a single 600-mg oral dose of rifapentine. Plasma samples were obtained at frequent intervals for up t
Publikováno v:
Journal of clinical pharmacology. 38(9)
In an open-label, randomized, two-way complete crossover study, the influence of renal impairment on the pharmacokinetics of dolasetron and its primary active metabolite, hydrodolasetron, were evaluated. Patients with renal impairment were stratified